The mechanisms of action involve modulation of sleep-regulating neurotransmitters and neuroendocrine systems including enhancement of delta wave activity during deep sleep stages, regulation of cortisol and stress hormone rhythms that impact sleep quality, optimization of circadian rhythm signaling for proper sleep-wake cycles, support for melatonin and sleep-promoting pathways, and modulation of pain perception which can interfere with sleep quality

Dosing, Administration, and Best Practices Recommended Dosing Protocols Dosing for BPC-157 TB-500 nasal spray varies based on individual goals, body weight, and the specific concentration of the formulation: Typical BPC-157 Dosing Maintenance: 250-500 mcg per day Active recovery: 500-750 mcg per day Acute injury: 750-1000 mcg per day (divided doses) Typical TB-500 Dosing Maintenance: 2-2.5 mg twice weekly Loading phase: 5-10 mg weekly (first 4-6 weeks) Maintenance phase: 2-5 mg weekly thereafter Combined Nasal Spray Formulations often provide both peptides in ratios designed for convenient once or twice-daily administration
Cellular regulation of islet hormone secretion by the incretin hormone glucagon-like peptide 1
In contrast, the ANG 1-7 peptide synthesized by ACE2 activity affect pro-oxidant pathways, preventing or attenuating cell damage induced by oxidative stress